Back Pain Doctor
Rotator Cuff & Shoulder Pain
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Most shoulder pain in adults comes from the rotator cuff tendons rather than from a single dramatic injury. Tendinopathy develops when the tendon is loaded more than it can tolerate, leading to pain and reduced function, particularly with overhead tasks.
Rehabilitation is the foundation of treatment. A structured, progressive exercise program to restore strength and control of the shoulder is well-evidenced and resolves symptoms for many people, although it takes time.
Where pain persists despite good rehabilitation, additional options may be considered. Shockwave therapy (ESWT) has a substantial evidence base for rotator cuff tendinopathy, including calcific tendinopathy, and EMTT is sometimes used as an adjunct. Assessment looks carefully at the shoulder and recommends the approach that best fits the diagnosis.
Pain located directly on top of the shoulder, particularly after landing on it, points away from the rotator cuff and towards an AC joint injury.
Common symptoms
- Pain on the outer shoulder, often worse with overhead movement
- Pain at night, particularly lying on the affected side
- Weakness or difficulty lifting or reaching
- A painful arc of movement when raising the arm
Commonly seen in
Evidence for twelve treatment options in rotator cuff & shoulder pain
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Loading is the treatment, and the trials say adjuncts add little to it. A living network meta-analysis of 68 randomised trials across Achilles and patellar tendinopathy and gluteal tendinopathy found no convincing evidence that any adjunct, alone or added to exercise, beats exercise by itself, and recommended exercise alone for at least three months before an adjunct is considered (Challoumas, Sports Med Open 2023). A meta-analysis of 110 studies and 3,953 patients found greater effect where the programme added external load rather than body weight alone, and where sessions were less frequent than daily, allowing recovery (Pavlova, Br J Sports Med 2023). A 204-study synthesis found exercise safe, beneficial and acceptable to patients, with no clear superiority for the eccentric-only protocols long treated as standard (Cooper, Health Technol Assess 2023).
Pairing reviewed 2026-09-02.
Where it fits
This is the plan, not the preliminary. Expect a programme measured in months rather than weeks, with load progressed against your symptoms. Anything else offered here is an adjunct to it, and the evidence for adding one before three months of proper loading is weak.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Small trials only
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Trigger point injection has been tested in this condition, in small trials. Twenty-one people with rotator cuff disease and upper arm pain were randomised to ultrasound-guided trigger point injection of the brachialis or to an oral anti-inflammatory: pain fell from 7.3 to 4.5 out of 10 with the injection against 7.4 to 5.9 with the tablets, a difference of 2.8 points against 1.5 that favoured the injection (Suh, Ann Rehabil Med 2014). In a larger randomised trial, 50 people with subacromial pain syndrome were given a rotator cuff exercise programme with or without two sessions of trigger point needling; the needling group had better arm and shoulder disability scores at every follow-up out to twelve months, but the two groups improved equally on pain (Arias-Buría, J Pain 2016). The Dutch Orthopaedic Association guideline for subacromial pain syndrome lists treatment of myofascial trigger points as something that may be considered within exercise therapy (Diercks, Acta Orthop 2014).
Pairing reviewed 2026-09-11.
Where it fits
Directed at a tender muscle band in the shoulder girdle or upper arm that reproduces part of your pain, alongside the loading programme. It does not treat the tendon itself.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Worth discussing
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Ultrasound guidance improves needle placement but not, at this target, the result. A meta-analysis of 15 trials found no advantage over blind injection at the subacromial bursa for pain or function (Fan, Arthroscopy 2021), and a randomised trial found no difference at 6 weeks (Cole, Am J Sports Med 2016). One trial did find better passive abduction with guidance (Hsieh, Med Sci Sports Exerc 2013).
Pairing reviewed 2026-08-30.
Where it fits
Used where the anatomy or a previous failed injection makes placement the question. See the note on cortisone for why the number is kept low.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Tested: no benefit
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searched 18 October 2026: radial shockwave with rotator cuff, supraspinatus, subacromial, impingement or shoulder pain (48 shockwave records screened, 20 randomised trials), plus a pass for non-calcific disease (24 records). This is evidence of absence, not absence of evidence. In a double-blind multicentre trial of 82 people with chronic rotator cuff tendinitis, low-dose radial shockwave was no better than placebo for pain or function at three and six months (Kolk, Bone Joint J 2013). In a sham-controlled trial of 143 people with subacromial pain, all doing supervised exercise, radial shockwave added nothing at 24 weeks (difference 0.7 points on the SPADI, 95% CI -6.9 to 8.3) or at one year, and the authors advise against it (Kvalvaag, Am J Sports Med 2017; Eur J Phys Rehabil Med 2018). In 104 people, supervised exercise did better than radial shockwave to 18 weeks (8.4 SPADI points) and fewer needed further treatment (Engebretsen, BMJ 2009). In 46 people with non-calcific cuff tendinopathy, radial did worse than focused shockwave at 24 and 48 weeks (Li, Biomed Res Int 2021). A pooled analysis of nine sham-controlled trials of any shockwave device in non-calcific disease found only a small, short-term effect on pain (Kamonseki, Am J Phys Med Rehabil 2024). The one positive radial trial compared it with passive heat and electrical treatments, not sham, in 60 people with partial tears (Wang, J Clin Med 2026). The only benefit in the sham-controlled trial was in people with a calcific deposit, and it did not last.
Pairing reviewed 2026-10-18.
Where it fits
Not offered for rotator cuff pain without calcification, because the controlled trials found it adds nothing to exercise. The loading program is the treatment that changes the course. Where a calcific deposit is present the evidence is different; see the calcific tendinopathy guide.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Evidence mixed
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
For rotator cuff pain WITHOUT calcification the Cochrane review of 32 trials found improvements that favour shockwave but fall below the clinically important threshold. Pain 0.78 points where 1.5 matters, function 7.9 points where 10 matters, both moderate-quality evidence (Surace, Cochrane 2020). High-energy shockwave was no better than placebo in non-calcific disease specifically (Bannuru, Ann Intern Med 2014).
Pairing reviewed 2026-08-30.
Where it fits
Where a calcific deposit is present the picture is quite different and much stronger: see the calcific tendinopathy guide. For non-calcific cuff pain, loading remains the treatment that changes the course.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Modest edge over cortisone, not saline
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Searched 20 October 2026: platelet-rich plasma with rotator cuff tendinopathy or tendinitis, supraspinatus tendinopathy, subacromial impingement or pain, or rotator cuff disease, restricted to randomised trials and systematic reviews (41 records, all read; one retracted trial excluded). Against a dummy injection the results are weak. In the one adequately sized saline-controlled trial, 40 people all doing a six-week exercise program, an ultrasound-guided PRP injection under the acromion was no better than saline on pain or function at any point to one year (Kesikburun, Am J Sports Med 2013). A review of five trials found no difference from saline when both groups exercised, and worse results with PRP alone than with a formal exercise program (Hurley, Arthroscopy 2019). Pooling five trials against sham, no injection or physiotherapy, the two were indistinguishable to six months, with a small pain advantage for PRP later (standardised difference 0.42) (Lin, Diagnostics 2020), and a review of ultrasound-guided PRP found no clear difference in the cuff at low or very low certainty (Masiello, Blood Transfus 2022). Against cortisone, PRP is slower and modestly better later. Pooling ten trials and 591 people, there was no difference to three months, and at six months PRP gave 0.8 points less pain on the 0 to 10 scale and about 11 points better on shoulder function scores, with fewer side effects (Yuwarungsikul, Knee Surg Sports Traumatol Arthrosc 2026); two other pooled analyses found that none of the differences reached the size patients notice (Pang, Arthroscopy 2022; Peng, J Shoulder Elbow Surg 2023). The best single trial, double-blind in 100 people aged 18 to 50, found less pain and fewer treatment failures at one year with one PRP injection than with cortisone (12% against 30%) (Rossi, J Shoulder Elbow Surg 2024). Added to an operation, PRP did no better than the operation alone (Carr, Am J Sports Med 2015; O'Dowd, Orthop J Sports Med 2022). Short-lived pain after the injection is more common with PRP (Masiello 2022).
Pairing reviewed 2026-10-20.
Where it fits
An option that can be discussed for cuff-related shoulder pain that has not settled with a proper course of cuff strengthening, usually where a cortisone injection is being considered: on these trials PRP is slower than cortisone and modestly better at six months, but it has not been shown to beat a saline injection. If used, it is placed under ultrasound guidance and the rehabilitation program continues. It is not added to a surgical repair.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Trials disagree; newest review null
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
Trials exist and disagree. The newest pooled analysis, of 14 studies (13 randomised) in rotator cuff tendinopathy and subacromial bursitis, found dextrose may have little to no benefit over saline (pain-related function SMD -0.3, 95% CI -1.0 to 0.4; three trials, 149 people; very low certainty) and probably worse physical performance than a cortisone injection; ten of the fourteen studies were at high risk of bias (Zerzan, PM R 2026). Against saline, the results split: three monthly dextrose injections onto the painful tendon attachments, given with physiotherapy, left 59% with a meaningful pain improvement at nine months against 27% given saline above the tendon (p=0.017), though the gap from saline injected onto the attachments (37%) did not reach significance (Bertrand, Arch Phys Med Rehabil 2016, 73 people); one 20% dextrose injection at the supraspinatus beat saline on pain and disability at two weeks but not at six (Lin, Eur J Phys Rehabil Med 2019, 31 people); and three bursal injections of 15% dextrose did no better than saline at three months (Chang, Arch Phys Med Rehabil 2021, 50 people). Against exercise alone, 120 people with chronic cuff problems given ultrasound-guided prolotherapy did better on pain and function to at least one year, without blinding (93% against 57% rating the outcome good or excellent; Seven, Orthop Traumatol Surg Res 2017). Against cortisone, a double-blind trial of 54 people with chronic subacromial bursitis found cortisone better on pain at two and six weeks and on disability to twelve weeks (Lin, Am J Phys Med Rehabil 2023).
Pairing reviewed 2026-10-16.
Where it fits
Can be discussed for persistent cuff-related pain that has not settled with a well-run loading program, particularly where cortisone has already been used or is unsuitable, on the understanding that the trials conflict and the newest review found little benefit over saline. It sits alongside the loading program and does not replace it.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used for tendons
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Not offered here. A meta-analysis of 19 randomised trials of hyaluronic acid in soft-tissue problems, 1,629 patients in all, reported less pain than the comparison treatments overall, but its rotator cuff group was ten trials whose results scattered badly, with heterogeneity of 94% (Khan, Sports Health 2022). These are injections around a tendon, which is a different procedure from the joint injection in this row.
Pairing reviewed 2026-10-05.
Where it fits
Not offered for this problem. Hyaluronic acid is considered only for a problem inside a joint, and this is a tendon problem.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Evidence mixed
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
One randomised sham-controlled trial has tested it here. Thirty-nine people with rotator cuff tendinopathy received 5% dextrose around either the upper or the lower part of the axillary nerve, or a sham injection, all alongside home exercise. The lower injection site reduced pain more than sham at two and four weeks (about 2.5 points on a 10-point scale, falling to 1.5 by four weeks); the upper site did no better than sham, and neither site improved shoulder function scores or range of motion (Vitoonpong, Asian Biomedicine 2026).
Pairing reviewed 2026-09-05.
Where it fits
A short-term pain option, not a tendon treatment. The trial that found a benefit still had everyone doing exercises, and function did not shift. Considered where pain is blocking progress with loading work, and only where the examination points to nerve-related pain around the shoulder.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
No trial has tested hydrodissection in rotator cuff tendinopathy itself. The nearest tissue-plane work is elsewhere around the shoulder: in a double-blind trial of 35 people with chronic myofascial shoulder pain, 10 mL of 10% dextrose injected between fascial layers under ultrasound reduced pain more than a sham injection at 12 weeks, with no difference in range of motion or function (Hsu, Am J Phys Med Rehabil 2024); and a small pilot in thickened, adherent subacromial bursitis found ultrasound-guided hydrodilation of the bursa relieved pain as well as a blind cortisone injection, with nobody in the hydrodilation group needing a repeat (Al Khayyat, J Ultrasound 2024). The axillary nerve dextrose trial in this condition used perineural injection and is covered in that row.
Pairing reviewed 2026-09-29.
Where it fits
Only where examination points to a nerve or fascial pain source around the shoulder alongside the tendon; the suprascapular and axillary nerves are the usual candidates. Loading-based rehabilitation remains the treatment for the tendon.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other shoulder conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Related articles
Shorter articles that answer the questions patients ask most often about this.
- Rotator Cuff Pain: Why Scan Results Do Not Tell the Whole StoryShoulder ultrasound or MRI often shows tendon changes. Why the scan report has to be read alongside symptoms, strength and the examination.
- Shoulder Pain: Causes, Symptoms, and Effective Treatment StrategiesRotator cuff injury, frozen shoulder and shoulder arthritis are common causes of shoulder pain. How they present and what treatment involves.
Frequently asked questions
Does calcific tendinopathy need surgery?
How long does rotator cuff pain take to improve?
Is a scan needed?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment